MIL-47(V) catalytic conversion of H2O2 for sensitive H2O2 detection and tumor cell inhibition

2022 ◽  
Vol 354 ◽  
pp. 131201
Author(s):  
Xuelian Yang ◽  
Wei Qiu ◽  
Rongwei Gao ◽  
Youpeng Wang ◽  
Yu Bai ◽  
...  
Keyword(s):  
Tumor Cell ◽  
Catalytic Conversion ◽  
H2o2 Detection ◽  
Cell Inhibition

Levels of viral glycoprotein provide a dose-dependent measure of tumor cell inhibition

Life Sciences ◽  
1989 ◽  
Vol 44 (26) ◽  
pp. 2041-2050 ◽  
Author(s):  
Earl M. Ritzi ◽  
Suhkneung Pyo
Keyword(s):  
Tumor Cell ◽  
Dependent Measure ◽  
Viral Glycoprotein ◽  
Cell Inhibition ◽  
Dose Dependent

Selective Tumor Cell Inhibition Effect of Ni–Ti Layered Double Hydroxides Thin Films Driven by the Reversed pH Gradients of Tumor Cells

2015 ◽  
Vol 7 (15) ◽  
pp. 7843-7854 ◽  
Author(s):  
Donghui Wang ◽  
Naijian Ge ◽  
Jinhua Li ◽  
Yuqin Qiao ◽  
Hongqin Zhu ◽  
...  
Keyword(s):  
Thin Films ◽  
Tumor Cell ◽  
Tumor Cells ◽  
Layered Double Hydroxides ◽  
Ph Gradients ◽  
Inhibition Effect ◽  
Cell Inhibition ◽  
Double Hydroxides

scholarly journals Caveolin-1 regulates EGFR signalling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition

2009 ◽  
Vol 8 (15) ◽  
pp. 1470-1477 ◽  
Author(s):  
Sophia Agelaki ◽  
Maria Spiliotaki ◽  
Harris Markomanolaki ◽  
Galatea Kallergi ◽  
Dimitris Mavroudis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Tumor Cell ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Caveolin 1 ◽  
Cell Inhibition ◽  
Mcf 7

Ferroptosis Photoinduced by New Cyclometalated Iridium(III) Complexes and Its Synergism with Apoptosis in Tumor Cell Inhibition

2021 ◽  
Vol 60 (15) ◽  
pp. 8174-8181
Author(s):  
Hao Yuan ◽  
Zhong Han ◽  
Yuncong Chen ◽  
Fen Qi ◽  
Hongbao Fang ◽  
...  
Keyword(s):  
Tumor Cell ◽  
Cell Inhibition

Ferroptosis Photoinduced by New Cyclometalated Iridium(III) Complexes and Its Synergism with Apoptosis in Tumor Cell Inhibition

2021 ◽  
Author(s):  
Hao Yuan ◽  
Zhong Han ◽  
Yuncong Chen ◽  
Fen Qi ◽  
Hongbao Fang ◽  
...  
Keyword(s):  
Tumor Cell ◽  
Cell Inhibition

scholarly journals Effectiveness of a Fractionated Therapy Scheme in Tumor Treating Fields Therapy

2019 ◽  
Vol 18 ◽  
pp. 153303381984500 ◽  
Author(s):  
Yunhui Jo ◽  
Jiwon Sung ◽  
Hyesun Jeong ◽  
Sunghoi Hong ◽  
Youn Kyoung Jeong ◽  
...  
Keyword(s):  
Tumor Cell ◽  
Treatment Duration ◽  
Treatment Time ◽  
Cell Number ◽  
Experimental Result ◽  
Normal Cells ◽  
Tumor Treating Fields ◽  
Biological Effectiveness ◽  
The Difference ◽  
Cell Inhibition

This study aimed to evaluate the biological effectiveness of cancer therapy with tumor treating fields using a fractionated treatment scheme that was originally designed for radiotherapy. Discontinuous fractional tumor treating fields of an intensity of 0.9 to 1.2 V/cm and a frequency of 150 KHz were applied to U373 cancer cells and IEC6 normal cells for 3 days, with durations of 3, 6, 12, or 24 h/d. As the treatment duration of the tumor treating fields increased from 3 to 24 h/d, the relative tumor cell (U373) number (% of control) reduced in proportion to the treatment duration. Compared to a 25% cell number reduction (75% of control) for the group of 6 h/d treatment at 1.2 V/cm, only 5% (70% of control) and 8% (67% of control) of additional reductions were observed for the group of 12 and 24 h/d treatment, respectively. This experimental result indicates that the dependence on treatment duration in tumor cell inhibition was weakened distinctly at treatment duration over 6 h/d. For normal cells (IEC6), the relative cell number corresponding to the treatment time of the tumor treating fields at 1.2 V/cm of electric field strength was not decreased much for the treatment times of 3, 6, and 12 h/d, revealing 93.3%, 90.0%, and 89.3% relative cell numbers, respectively, but it suddenly decreased to ∼73% for the 24 h/d treatment. Our results showed that the effects of tumor treating fields on tumor cells were higher than on normal cells for treatment duration of 3 to 12 h/d, but the difference became minimal for treatment duration of 24 h/d. The fractionated scheme, using tumor treating fields, reduced the treatment time while maintaining efficacy, suggesting that this method may be clinically applicable for cancer treatment.

scholarly journals A novel gene transfer strategy that combines promoter and transgene activities for improved tumor cell inhibition

2005 ◽  
Vol 12 (12) ◽  
pp. 935-946 ◽  
Author(s):  
Bryan E Strauss ◽  
Marcio C Bajgelman ◽  
Eugenia Costanzi-Strauss
Keyword(s):  
Gene Transfer ◽  
Tumor Cell ◽  
Novel Gene ◽  
Cell Inhibition
Sign in / Sign up

Export Citation Format

Share Document